Who Paid My Doc
An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) (EAGLE)
Research payments
$591,058
Through program year 2024, $591,058 in research payments was reported against An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) (EAGLE), across 57 payments, paid by Biogen, Inc..
- Paid by
- Biogen, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $587,923 | 56 |
| 2023 | Research | $3,135 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Frederic Rahbari Oskoui Atlanta, GA Named on 2 payments
- Than Oo Kalamazoo, MI Named on 2 payments
- Stuart Sprague Evanston, IL Named on 1 payment
- Rasheed Gbadegesin Durham, NC Named on 1 payment
- Bernard Fischbach Fort Worth, TX Named on 1 payment
- Meyeon Park San Francisco, CA Named on 1 payment
- Dana Rizk Birmingham, AL Named on 1 payment
- Kenneth Lieberman Hackensack, NJ Named on 1 payment
- Marializa Bernardo Houston, TX Named on 1 payment
- Mohamed El-Shahawy Los Angeles, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.